tiprankstipranks
pc:gelme

GelMEDIX

GelMEDIX is a biotechnology company developing regenerative therapies to restore vision, focusing on cell-based treatments and biomaterials for retinal diseases. The company is advancing GMX-101, an RPE cell therapy for late-stage Geographic Atrophy, and a proprietary injectable hydrogel scaffold platform engineered to optimize delivery, efficacy, and safety of cell and gene therapies.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$13M
Total Amount Raised$13M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$13M
Latest Funding Amount$13M
Latest Funding RoundSeed Round
Latest Funding RoundSeed Round
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Feb 17, 2026
Seed Round
$13.00M

Investors

Investor Name
Funding Round

Related News and Analysis